Trials / Completed
CompletedNCT00352963
Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).
Study to Assess Immunogenicity and Reactogenicity of Three Doses of GSK Bio's Combined Hib-MenC Vaccine Co-admind With GSK Bio's DTPa-HBV-IPV Vaccine and of Two Doses of Baxters Meningococcal C Conjugate Vaccine Co-admind With GSK Bio's DTPa-HBV-IPV/Hib Vaccine
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 480 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 7 Days
- Healthy volunteers
- Accepted
Summary
This study will evaluate the immunogenicity of the co-administration of different combinations of DTPa, IPV, hepatitis B, Hib and Men C vaccines during the first year of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Study vaccines: IH+Hib-MenC/NVC; Control: IH+Meningitec |
Timeline
- Start date
- 2003-09-30
- Completion
- 2004-07-16
- First posted
- 2006-07-17
- Last updated
- 2020-01-06
Locations
22 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT00352963. Inclusion in this directory is not an endorsement.